tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PTN Stock Latest News

Palatin Technologies Reports Q2 2025 Financial Results
Company AnnouncementsPalatin Technologies Reports Q2 2025 Financial Results
7d ago
PTN
Palatin’s Earnings Call: Mixed Results and Strategic Moves
PremiumCompany Announcements
Palatin’s Earnings Call: Mixed Results and Strategic Moves
7d ago
PTN
Palatin price target lowered to $7 from $17 at H.C. Wainwright
PremiumThe Fly
Palatin price target lowered to $7 from $17 at H.C. Wainwright
7d ago
PTN
Palatin reports Q2 EPS (12c) vs. (56c) last year
PremiumThe Fly
Palatin reports Q2 EPS (12c) vs. (56c) last year
8d ago
PTN
Palatin to sell 4.69M shares at $1.00 in registered direct offering
PremiumThe Fly
Palatin to sell 4.69M shares at $1.00 in registered direct offering
14d ago
PTN
Palatin reports positive Phase 2b results in diabetic nephropathy
PremiumThe FlyPalatin reports positive Phase 2b results in diabetic nephropathy
2M ago
PTN
Palatin completes patient enrollment in Phase 2 study of PL8177
Premium
The Fly
Palatin completes patient enrollment in Phase 2 study of PL8177
3M ago
PTN
Palatin Technologies Shifts Focus to Obesity Treatments
Premium
Company Announcements
Palatin Technologies Shifts Focus to Obesity Treatments
3M ago
PTN
Palatin to report data from MC4R selective PL7737 obesity program
PremiumThe Fly
Palatin to report data from MC4R selective PL7737 obesity program
4M ago
PTN
Palatin completes enrollment in Phase 2 study of bremelanotide in obesity
PremiumThe Fly
Palatin completes enrollment in Phase 2 study of bremelanotide in obesity
4M ago
PTN
Palatin’s melanocortin agonists shows efficacy in inflammatory diseases
PremiumThe Fly
Palatin’s melanocortin agonists shows efficacy in inflammatory diseases
4M ago
PTN
Palatin receives notice of non-compliance from NYSE American
PremiumThe Fly
Palatin receives notice of non-compliance from NYSE American
5M ago
PTN
Palatin reports Q4 EPS (51c) vs (84c) last year
PremiumThe FlyPalatin reports Q4 EPS (51c) vs (84c) last year
5M ago
PTN
PTN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PTN Upcoming Earnings Report: What to Expect?
5M ago
PTN
Palatin provides update on its clinical programs
Premium
The Fly
Palatin provides update on its clinical programs
5M ago
PTN
Palatin: FDA confirms acceptability of Phase 3 pivotal clinical trials for PL964
PremiumThe Fly
Palatin: FDA confirms acceptability of Phase 3 pivotal clinical trials for PL964
6M ago
PTN
Palatin doses first patient in Phase 2 study of bremelanotide in obesity
PremiumThe Fly
Palatin doses first patient in Phase 2 study of bremelanotide in obesity
6M ago
PTN
Palatin files to sell 4.85M shares of common stock for holders
PremiumThe Fly
Palatin files to sell 4.85M shares of common stock for holders
7M ago
PTN
Palatin Technologies Secures Growth with Warrant Exercise Deal
PremiumCompany Announcements
Palatin Technologies Secures Growth with Warrant Exercise Deal
8M ago
8K
PTN
Palatin exercises warrants for gross proceeds of ~$6.1M
PremiumThe FlyPalatin exercises warrants for gross proceeds of ~$6.1M
8M ago
PTN
Palatin initiates Phase 2 clinical study of bremelanotide
Premium
The Fly
Palatin initiates Phase 2 clinical study of bremelanotide
8M ago
PTN
Palatin announces initiation of Phase 2 clinical study of bremelanotide
Premium
The Fly
Palatin announces initiation of Phase 2 clinical study of bremelanotide
8M ago
PTN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >